🚀 VC round data is live in beta, check it out!
Brainscan Valuation Multiples
Discover revenue and EBITDA valuation multiples for Brainscan and similar public comparables like Prostatype Genomics, Genetic Analysis, Cykel AI, Spermosens and more.
Brainscan Overview
About Brainscan
Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes.
Founded
2017
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$5M
Brainscan Financials
Brainscan reported last fiscal year revenue of $119K and negative EBITDA of ($766K).
In the same fiscal year, Brainscan generated $114K in gross profit, ($766K) in EBITDA losses, and had net loss of ($785K).
Brainscan P&L
In the most recent fiscal year, Brainscan reported revenue of $119K and EBITDA of ($766K).
Brainscan expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $119K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $114K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 96% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($766K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (644%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (641%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($785K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (661%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Brainscan Stock Performance
Brainscan has current market cap of $5M, and enterprise value of $5M.
Market Cap Evolution
Brainscan's stock price is $4.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $5M | 0.1% | XXX | XXX | XXX | $-0.62 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrainscan Valuation Multiples
Brainscan trades at 39.7x EV/Revenue multiple, and (6.2x) EV/EBITDA.
Brainscan Financial Valuation Multiples
As of April 20, 2026, Brainscan has market cap of $5M and EV of $5M.
Equity research analysts estimate Brainscan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Brainscan has a P/E ratio of (6.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 39.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (6.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (6.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 41.4x | XXX | XXX | XXX |
| P/E | — | XXX | (6.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 25.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Brainscan Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Brainscan Margins & Growth Rates
Brainscan's revenue in the last fiscal year grew by 100%.
Brainscan Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 100% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (644%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (42%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 737% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Brainscan Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics and Artificial Intelligence comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Brainscan | XXX | XXX | XXX | XXX | XXX | XXX |
| Prostatype Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Genetic Analysis | XXX | XXX | XXX | XXX | XXX | XXX |
| Cykel AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Spermosens | XXX | XXX | XXX | XXX | XXX | XXX |
| Elite Diagnostic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Brainscan M&A Activity
Brainscan acquired XXX companies to date.
Last acquisition by Brainscan was on XXXXXXXX, XXXXX. Brainscan acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Brainscan
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBrainscan Investment Activity
Brainscan invested in XXX companies to date.
Brainscan made its latest investment on XXXXXXXX, XXXXX. Brainscan invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Brainscan
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Brainscan
| When was Brainscan founded? | Brainscan was founded in 2017. |
| Where is Brainscan headquartered? | Brainscan is headquartered in Poland. |
| Is Brainscan publicly listed? | Yes, Brainscan is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Brainscan? | Brainscan trades under BSN ticker. |
| When did Brainscan go public? | Brainscan went public in 2024. |
| Who are competitors of Brainscan? | Brainscan main competitors are Prostatype Genomics, Genetic Analysis, Cykel AI, Spermosens. |
| What is the current market cap of Brainscan? | Brainscan's current market cap is $5M. |
| What is the current revenue of Brainscan? | Brainscan's last fiscal year revenue is $119K. |
| What is the current EV/Revenue multiple of Brainscan? | Current revenue multiple of Brainscan is 39.7x. |
| Is Brainscan profitable? | No, Brainscan is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.